These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2129354)

  • 1. Risk factors of system clotting in heparin-free haemodialysis.
    Keller F; Seemann J; Preuschof L; Offermann G
    Nephrol Dial Transplant; 1990; 5(9):802-7. PubMed ID: 2129354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-free hemodialysis with prophylactic change of dialyser and blood lines.
    Preuschof L; Keller F; Seemann J; Offermann G
    Int J Artif Organs; 1988 Jul; 11(4):255-8. PubMed ID: 3410566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodialysis without anticoagulant: haemostasis parameters, fibrinogen kinetic, and dialysis efficiency.
    Româo JE; Fadil MA; Sabbaga E; Marcondes M
    Nephrol Dial Transplant; 1997 Jan; 12(1):106-10. PubMed ID: 9027783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
    Skagerlind MSE; Stegmayr BG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vitamin-E-modified dialysers on dialyser clotting, erythropoietin and heparin dosage: a comparative crossover study.
    Huraib S; Tanimu D; Shaheen F; Hejaili F; Giles C; Pagayon V
    Am J Nephrol; 2000; 20(5):364-8. PubMed ID: 11092992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin free dialysis: comparative data and results in high risk patients.
    Caruana RJ; Raja RM; Bush JV; Kramer MS; Goldstein SJ
    Kidney Int; 1987 Jun; 31(6):1351-5. PubMed ID: 3613407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.
    Anastassiades E; Ireland H; Flynn A; Lane DA; Curtis JR
    Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional anticoagulation with citrate in hemodialysis in patients with a high risk for hemorrhage].
    Perdrix JP; Lepape A; Gronlier T; Grozel JM; Banssillon V
    Ann Fr Anesth Reanim; 1988; 7(1):31-5. PubMed ID: 3348512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
    Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
    Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of blood loss in dialysers with DEAE-cellulose membranes does not require increased doses of heparin.
    Ward RA; Schmidt B; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(10):1140-5. PubMed ID: 8272230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
    Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin.
    Sagedal S; Hartmann A; Osnes K; Bjørnsen S; Torremocha J; Fauchald P; Kofstad J; Brosstad F
    Nephrol Dial Transplant; 2006 Feb; 21(2):444-9. PubMed ID: 16234293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minimal heparinization in dialysis patients with increased risk of bleeding].
    Klingel R; Wandel E; Hafner G; Meyer zum Büschenfelde KH; Köhler H
    Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1878-83. PubMed ID: 8287777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
    Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of coagulation and platelet functions in heparin-free hemodialysis.
    Ivanovich P; Xu CG; Kwaan HC; Hathiwala S
    Nephron; 1983; 33(2):116-20. PubMed ID: 6835458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
    Sabry A; Taha M; Nada M; Al Fawzan F; Alsaran K
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):57-62. PubMed ID: 20523166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of biomaterials as components of a reciprocating dialyser during canine dialysis.
    Davidson GW; Peppas NA; Thornhill JA; Ash SR
    Biomaterials; 1984 Jul; 5(4):227-33. PubMed ID: 6487703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory control of minimal heparinization during haemodialysis in patients with a risk of haemorrhage.
    Hafner G; Klingel R; Wandel E; Ehrenthal W; Konheiser U; Lotz J; Köhler H; Prellwitz W
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):221-6. PubMed ID: 8054454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.